NetworkNewsBreaks – CannAssist International Cor
Post# of 77
(Total Views: 232)
Posted On: 01/29/2021 4:17:55 PM
NetworkNewsBreaks – CannAssist International Corporation (CNSC) Leverages Proprietary Technology to Stand Distinct in Surging Market
CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, rapidly garnered a reputation and loyal following due to its innovative technology and proprietary product line, marketed through its Xceptol consumer brand. The company was founded in May 2017 and moved to the forefront of the cannabidiol industry following the passing of the 2018 Farm Bill, whereby the United States effectively decriminalized the cultivation and use of hemp and its derivative products. The global cannabidiol (“CBD”) industry has since surged to new heights, set to rise from a market value of $4.6 billion in 2018 to an estimated $23.6 billion by 2025 (https://nnw.fm/o2AJa). A recent article discusses the company’s positioning in this market. It reads, “In a sector which has seen its ranks rapidly swell given an influx of new entrants, CannAssist’s wholly owned Xceptor Labs has sought to differentiate itself through the use and development of its CiBiDinol technology. CiBiDinol technology is comprised of a proprietary process specifically designed to address a number of the shortcomings currently afflicting oil-soluble CBD molecules – namely, the delivery, bioavailability and short shelf-life.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, rapidly garnered a reputation and loyal following due to its innovative technology and proprietary product line, marketed through its Xceptol consumer brand. The company was founded in May 2017 and moved to the forefront of the cannabidiol industry following the passing of the 2018 Farm Bill, whereby the United States effectively decriminalized the cultivation and use of hemp and its derivative products. The global cannabidiol (“CBD”) industry has since surged to new heights, set to rise from a market value of $4.6 billion in 2018 to an estimated $23.6 billion by 2025 (https://nnw.fm/o2AJa). A recent article discusses the company’s positioning in this market. It reads, “In a sector which has seen its ranks rapidly swell given an influx of new entrants, CannAssist’s wholly owned Xceptor Labs has sought to differentiate itself through the use and development of its CiBiDinol technology. CiBiDinol technology is comprised of a proprietary process specifically designed to address a number of the shortcomings currently afflicting oil-soluble CBD molecules – namely, the delivery, bioavailability and short shelf-life.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)